---
document_datetime: 2023-09-21 21:03:38
document_pages: 3
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/vfend-epar-all-authorised-presentations_en.pdf
document_name: vfend-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 4.4725482
conversion_datetime: 2025-12-28 08:36:00.905542
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| MA (EU) NUMBER   | (Invented) Name   | Strength   | Pharmaceutical Form   | Route of Administration   | Immediate Packaging   | Pack Size   |
|------------------|-------------------|------------|-----------------------|---------------------------|-----------------------|-------------|
| EU/1/02/212/001  | Vfend             | 50 mg      | Film-coated tablet    | Oral use                  | blister (PVC/alu)     | 2 tablets   |
| EU/1/02/212/002  | Vfend             | 50 mg      | Film-coated tablet    | Oral use                  | blister (PVC/alu)     | 10 tablets  |
| EU/1/02/212/003  | Vfend             | 50 mg      | Film-coated tablet    | Oral use                  | blister (PVC/alu)     | 14 tablets  |
| EU/1/02/212/004  | Vfend             | 50 mg      | Film-coated tablet    | Oral use                  | blister (PVC/alu)     | 20 tablets  |
| EU/1/02/212/005  | Vfend             | 50 mg      | Film-coated tablet    | Oral use                  | blister (PVC/alu)     | 28 tablets  |
| EU/1/02/212/006  | Vfend             | 50 mg      | Film-coated tablet    | Oral use                  | blister (PVC/alu)     | 30 tablets  |
| EU/1/02/212/007  | Vfend             | 50 mg      | Film-coated tablet    | Oral use                  | blister (PVC/alu)     | 50 tablets  |
| EU/1/02/212/008  | Vfend             | 50 mg      | Film-coated tablet    | Oral use                  | blister (PVC/alu)     | 56 tablets  |
| EU/1/02/212/009  | Vfend             | 50 mg      | Film-coated tablet    | Oral use                  | blister (PVC/alu)     | 100 tablets |
| EU/1/02/212/013  | Vfend             | 200 mg     | Film-coated tablet    | Oral use                  | blister (PVC/alu)     | 2 tablets   |
| EU/1/02/212/014  | Vfend             | 200 mg     | Film-coated tablet    | Oral use                  | blister (PVC/alu)     | 10 tablets  |
| EU/1/02/212/015  | Vfend             | 200 mg     | Film-coated tablet    | Oral use                  | blister (PVC/alu)     | 14 tablets  |
| EU/1/02/212/016  | Vfend             | 200 mg     | Film-coated tablet    | Oral use                  | blister (PVC/alu)     | 20 tablets  |
| EU/1/02/212/017  | Vfend             | 200 mg     | Film-coated tablet    | Oral use                  | blister (PVC/alu)     | 28 tablets  |
| EU/1/02/212/018  | Vfend             | 200 mg     | Film-coated tablet    | Oral use                  | blister (PVC/alu)     | 30 tablets  |
| EU/1/02/212/019  | Vfend             | 200 mg     | Film-coated tablet    | Oral use                  | blister (PVC/alu)     | 50 tablets  |
| EU/1/02/212/020  | Vfend             | 200 mg     | Film-coated tablet    | Oral use                  | blister (PVC/alu)     | 56 tablets  |
| EU/1/02/212/021  | Vfend             | 200 mg     | Film-coated           | Oral use                  | blister (PVC/alu)     | 100 tablets |
| EU/1/02/212/025  | Vfend             | 200 mg     | Powder for            | 1/3 Intravenous use       | vial (glass)          | 1 vial      |

<div style=\"page-break-after: always\"></div>

| MA (EU) NUMBER   | (Invented) Name   | Strength   | Pharmaceutical Form solution for infusion   | Route of Administration   | Immediate Packaging        | Pack Size   |
|------------------|-------------------|------------|---------------------------------------------|---------------------------|----------------------------|-------------|
| EU/1/02/212/026  | Vfend             | 40 mg/ml   | Powder for oral suspension                  | Oral use                  | bottle (HDPE)              | 1 bottle    |
| EU/1/02/212/028  | Vfend             | 50 mg      | Film-coated tablet                          | Oral use                  | blister (PVC/alu/PVC/PVDC) | 2 tablets   |
| EU/1/02/212/029  | Vfend             | 50 mg      | Film-coated tablet                          | Oral use                  | blister (PVC/alu/PVC/PVDC) | 10 tablets  |
| EU/1/02/212/030  | Vfend             | 50 mg      | Film-coated tablet                          | Oral use                  | blister (PVC/alu/PVC/PVDC) | 14 tablets  |
| EU/1/02/212/031  | Vfend             | 50 mg      | Film-coated tablet                          | Oral use                  | blister (PVC/alu/PVC/PVDC) | 20 tablets  |
| EU/1/02/212/032  | Vfend             | 50 mg      | Film-coated tablet                          | Oral use                  | blister (PVC/alu/PVC/PVDC) | 28 tablets  |
| EU/1/02/212/033  | Vfend             | 50 mg      | Film-coated tablet                          | Oral use                  | blister (PVC/alu/PVC/PVDC) | 30 tablets  |
| EU/1/02/212/034  | Vfend             | 50 mg      | Film-coated tablet                          | Oral use                  | blister (PVC/alu/PVC/PVDC) | 50 tablets  |
| EU/1/02/212/035  | Vfend             | 50 mg      | Film-coated tablet                          | Oral use                  | blister (PVC/alu/PVC/PVDC) | 56 tablets  |
| EU/1/02/212/036  | Vfend             | 50 mg      | Film-coated tablet                          | Oral use                  | blister (PVC/alu/PVC/PVDC) | 100 tablets |
| EU/1/02/212/037  | Vfend             | 200 mg     | Film-coated tablet                          | Oral use                  | blister (PVC/alu/PVC/PVDC) | 2 tablets   |
| EU/1/02/212/038  | Vfend             | 200 mg     | Film-coated tablet                          | Oral use                  | blister (PVC/alu/PVC/PVDC) | 10 tablets  |
| EU/1/02/212/039  | Vfend             | 200 mg     | Film-coated tablet                          | Oral use                  | blister (PVC/alu/PVC/PVDC) | 14 tablets  |
| EU/1/02/212/040  | Vfend             | 200 mg     | Film-coated tablet                          | Oral use                  | blister (PVC/alu/PVC/PVDC) | 20 tablets  |

<div style=\"page-break-after: always\"></div>

| MA (EU) NUMBER   | (Invented) Name   | Strength   | Pharmaceutical Form   | Route of Administration Oral use   | Immediate Packaging blister   | Content (concentration)   | Pack Size   |
|------------------|-------------------|------------|-----------------------|------------------------------------|-------------------------------|---------------------------|-------------|
| EU/1/02/212/041  | Vfend             | 200 mg     | Film-coated tablet    |                                    | (PVC/alu/PVC/PVDC)            |                           | 28 tablets  |
| EU/1/02/212/042  | Vfend             | 200 mg     | Film-coated tablet    | Oral use                           | blister (PVC/alu/PVC/PVDC)    |                           | 30 tablets  |
| EU/1/02/212/043  | Vfend             | 200 mg     | Film-coated tablet    | Oral use                           | blister (PVC/alu/PVC/PVDC)    |                           | 50 tablets  |
| EU/1/02/212/044  | Vfend             | 200 mg     | Film-coated tablet    | Oral use                           | blister (PVC/alu/PVC/PVDC)    |                           | 56 tablets  |
| EU/1/02/212/045  | Vfend             | 200 mg     | Film-coated tablet    | Oral use                           | blister (PVC/alu/PVC/PVDC)    |                           | 100 tablets |